18 - 20 June 2017
This meeting, organized by SCI's Fine Chemicals Group and RSC's Biological and Medicinal Chemistry Sector, will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health.
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (e.g. dengue, West Nile), kinetoplastids (e.g. Chagas disease, leishmaniasis) and parasitic worms (e.g. filariasis), remain a cause of high mortality across the globe. However, an ever-improving understanding of the complex life-cycles of the disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.
Keynote talks from international experts, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst showcasing the opportunity for creativity and innovation.
MMV's Brice Campo is speaking on Monday, 19 June about MMV’s strategy and recent advances for P. vivax radical cure